Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001497497 | SCV001702228 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-04-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501711 | SCV002811901 | likely benign | Hypertrophic cardiomyopathy 1; Dilated cardiomyopathy 1EE; Hypertrophic cardiomyopathy 14; Atrial septal defect 3; Sick sinus syndrome 3, susceptibility to | 2021-07-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004641663 | SCV005143012 | likely benign | Cardiovascular phenotype | 2024-05-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |